F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Tyrosine kinase inhibitors

Page 1 of 1 ( 28 items )
<<
1
>>

1	Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials 1/16/2026 11:31:18 AM \| Browse: 90 \| Download: 279
2	Are we overestimating success of salvage hepatectomy in unresectable hepatocellular carcinoma? 9/23/2025 6:49:00 AM \| Browse: 108 \| Download: 298
3	Efficacy and safety of transarterial chemoembolization with chemotherapy, PD-1/PD-L1 inhibitors, and tyrosine kinase inhibitors in unresectable intrahepatic cholangiocarcinoma 9/15/2025 8:38:03 AM \| Browse: 376 \| Download: 525
4	Risk prediction of acute variceal bleeding in hepatocellular carcinoma patients undergoing systemic therapy based on immune checkpoint inhibitors 8/14/2025 5:49:33 AM \| Browse: 204 \| Download: 428
5	Immune therapies in intermediate-advanced unresectable hepatocellular carcinoma: Changing the therapeutic landscape 4/11/2025 2:19:33 AM \| Browse: 131 \| Download: 453
6	Characteristics and therapeutic strategies for familial gastrointestinal stromal tumors 2/14/2025 10:33:16 AM \| Browse: 175 \| Download: 684
7	Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy 11/12/2024 12:23:38 PM \| Browse: 176 \| Download: 682
8	Reassessment of palliative surgery in conversion therapy of previously unresectable hepatocellular carcinoma: Two case reports and review of literature 9/28/2024 4:34:25 AM \| Browse: 216 \| Download: 764
9	Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma 7/12/2024 3:55:58 PM \| Browse: 209 \| Download: 1204
10	Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma 7/12/2024 3:55:58 PM \| Browse: 215 \| Download: 824
11	Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies 7/12/2024 3:55:58 PM \| Browse: 218 \| Download: 513
12	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 356 \| Download: 1178
13	Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer 5/19/2023 6:25:33 AM \| Browse: 297 \| Download: 1195
14	Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy? 7/27/2022 2:48:53 AM \| Browse: 720 \| Download: 1531
15	Is dose modification or discontinuation of nilotinib necessary in nilotinib-induced hyperbilirubinemia? 12/28/2021 9:18:59 AM \| Browse: 619 \| Download: 1647
16	First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series 11/19/2021 9:32:33 AM \| Browse: 651 \| Download: 1797
17	Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma 10/26/2021 8:04:00 AM \| Browse: 744 \| Download: 1736
18	Oncogenic driver mutations in non-small cell lung cancer: Past, present and future 4/20/2021 12:49:50 PM \| Browse: 741 \| Download: 1992
19	Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review 2/22/2021 12:47:36 PM \| Browse: 725 \| Download: 2078
20	Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia 12/18/2020 12:27:09 PM \| Browse: 921 \| Download: 2192
21	Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors 12/13/2018 6:32:35 AM \| Browse: 1140 \| Download: 2196
22	Gastrointestinal stromal tumors: A multidisciplinary challenge 5/11/2018 10:51:26 AM \| Browse: 1501 \| Download: 3342
23	Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience 1/19/2017 8:03:00 AM \| Browse: 1270 \| Download: 1837
24	Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis? 2/2/2016 6:35:00 PM \| Browse: 1502 \| Download: 2320
25	Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies 1/6/2016 4:13:00 PM \| Browse: 1618 \| Download: 2464
26	Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer? 8/17/2015 4:41:00 PM \| Browse: 1092 \| Download: 2133
27	Therapeutic targets in gastrointestinal stromal tumors 4/14/2015 5:36:00 PM \| Browse: 1338 \| Download: 2198
28	Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma 9/3/2014 12:05:00 PM \| Browse: 1326 \| Download: 1391

Page 1 of 1 ( 28 items )
<<
1
>>

1	Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials 1/16/2026 11:31:18 AM \| Browse: 90 \| Download: 279
2	Are we overestimating success of salvage hepatectomy in unresectable hepatocellular carcinoma? 9/23/2025 6:49:00 AM \| Browse: 108 \| Download: 298
3	Efficacy and safety of transarterial chemoembolization with chemotherapy, PD-1/PD-L1 inhibitors, and tyrosine kinase inhibitors in unresectable intrahepatic cholangiocarcinoma 9/15/2025 8:38:03 AM \| Browse: 376 \| Download: 525
4	Risk prediction of acute variceal bleeding in hepatocellular carcinoma patients undergoing systemic therapy based on immune checkpoint inhibitors 8/14/2025 5:49:33 AM \| Browse: 204 \| Download: 428
5	Immune therapies in intermediate-advanced unresectable hepatocellular carcinoma: Changing the therapeutic landscape 4/11/2025 2:19:33 AM \| Browse: 131 \| Download: 453
6	Characteristics and therapeutic strategies for familial gastrointestinal stromal tumors 2/14/2025 10:33:16 AM \| Browse: 175 \| Download: 684
7	Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy 11/12/2024 12:23:38 PM \| Browse: 176 \| Download: 682
8	Reassessment of palliative surgery in conversion therapy of previously unresectable hepatocellular carcinoma: Two case reports and review of literature 9/28/2024 4:34:25 AM \| Browse: 216 \| Download: 764
9	Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma 7/12/2024 3:55:58 PM \| Browse: 209 \| Download: 1204
10	Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma 7/12/2024 3:55:58 PM \| Browse: 215 \| Download: 824
11	Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies 7/12/2024 3:55:58 PM \| Browse: 218 \| Download: 513
12	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 356 \| Download: 1178
13	Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer 5/19/2023 6:25:33 AM \| Browse: 297 \| Download: 1195
14	Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy? 7/27/2022 2:48:53 AM \| Browse: 720 \| Download: 1531
15	Is dose modification or discontinuation of nilotinib necessary in nilotinib-induced hyperbilirubinemia? 12/28/2021 9:18:59 AM \| Browse: 619 \| Download: 1647
16	First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series 11/19/2021 9:32:33 AM \| Browse: 651 \| Download: 1797
17	Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma 10/26/2021 8:04:00 AM \| Browse: 744 \| Download: 1736
18	Oncogenic driver mutations in non-small cell lung cancer: Past, present and future 4/20/2021 12:49:50 PM \| Browse: 741 \| Download: 1992
19	Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review 2/22/2021 12:47:36 PM \| Browse: 725 \| Download: 2078
20	Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia 12/18/2020 12:27:09 PM \| Browse: 921 \| Download: 2192
21	Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors 12/13/2018 6:32:35 AM \| Browse: 1140 \| Download: 2196
22	Gastrointestinal stromal tumors: A multidisciplinary challenge 5/11/2018 10:51:26 AM \| Browse: 1501 \| Download: 3342
23	Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience 1/19/2017 8:03:00 AM \| Browse: 1270 \| Download: 1837
24	Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis? 2/2/2016 6:35:00 PM \| Browse: 1502 \| Download: 2320
25	Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies 1/6/2016 4:13:00 PM \| Browse: 1618 \| Download: 2464
26	Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer? 8/17/2015 4:41:00 PM \| Browse: 1092 \| Download: 2133
27	Therapeutic targets in gastrointestinal stromal tumors 4/14/2015 5:36:00 PM \| Browse: 1338 \| Download: 2198
28	Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma 9/3/2014 12:05:00 PM \| Browse: 1326 \| Download: 1391